AbbVie number of employees

AbbVie reported 57,000 employees at December 31, 2025 in its latest annual report, up 2,000 (3.6%) on the year before. That compares with 50,000 at December 31, 2021. Revenue per employee was $1.1m.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	57,000	+2,000 (3.6%)	$1.1m	10-K, filed February 20, 2026
December 31, 2024	55,000	+5,000 (10.0%)	$1.0m	10-K, filed February 14, 2025
December 31, 2023	50,000	+0 (0.0%)	$1.1m	10-K, filed February 20, 2024
December 31, 2022	50,000	+0 (0.0%)	$1.2m	10-K, filed February 17, 2023
December 31, 2021	50,000	—	$1.1m	10-K, filed February 18, 2022

What the annual reports say

Employees AbbVie employed approximately 57,000 employees in over 70 countries as of December 31, 2025. 2025 annual report
Employees AbbVie employed approximately 55,000 employees in over 70 countries as of January 31, 2025. 2024 annual report
Employees AbbVie employed approximately 50,000 employees in over 70 countries as of January 31, 2024. 2023 annual report
Employees AbbVie employed approximately 50,000 employees in over 70 countries as of January 31, 2023. 2022 annual report
Employees AbbVie employed approximately 50,000 employees in over 70 countries as of January 31, 2022. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: ABBV vs GILD ABBV vs REGN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from AbbVie's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to AbbVie.